SeekingAlphaAugust 12, 2026 at 7:45 AM NY23 days ago

Omada Health: Q2 Shows More Evidence Of Growth Converting Into Earnings

Omada Health (OMDA) delivered strong Q2 results, with 43% revenue growth, margin expansion, and positive adj. EBITDA, reinforcing my buy rating.

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — SeekingAlpha

Companies in This Story